ORIGINAL HISTOLOGICAL DIAGNOSIS | FINAL DIAGNOSIS AFTER IMMUNOHISTOCHEMISTRY | AGE GROUP (years) | GENDER | TOPOGRAPHY |
---|---|---|---|---|
Carcinoma | Neuroendocrine carcinoma | 25-44 | Male | Lymph node |
Carcinoma | Neuroendocrine carcinoma | 45-64 | Female | Nose |
Carcinoma | Neuroendocrine carcinoma | 45-64 | Male | Nasopharynx |
Carcinoma | Neuroendocrine carcinoma | 25-44 | Female | Nose |
Carcinoma | Neuroendocrine carcinoma | 15-24 | Male | Palate |
Carcinoma | Neuroendocrine carcinoma | ≥65 | Male | Nasopharynx |
Carcinoma | Sarcoma | 25-44 | Male | Face/scalp |
Carcinoma | Sarcoma | 15-24 | Male | Nasopharynx |
Carcinoma | Sarcoma | 45-64 | Male | Lymph node |
Carcinoma | Sarcoma | 25-44 | Male | Nasopharynx |
Carcinoma | Sarcoma | 25-44 | Male | Nose |
Carcinoma | Sarcoma | 15-24 | Male | Nose |
Carcinoma | Sarcoma | 45-64 | Male | Nasopharynx |
Carcinoma | Sarcoma | 45-64 | Female | Maxillofacial bone |
Carcinoma | Lymphoma | ≥65 | Male | Nasopharynx |
Carcinoma | Lymphoma | 45-64 | Male | Nasopharynx |
Carcinoma | Lymphoma | 25-44 | Male | Oropharynx |
Carcinoma | Lymphoma | ---- | Male | Oropharynx |
Carcinoma | Lymphoma | 15-24 | Male | Maxillofacial bone |
Carcinoma | Lymphoma | 45-64 | Male | Nose |
Carcinoma | Lymphoma | 25-44 | Female | Nasopharynx |
Carcinoma | Lymphoma | 45-64 | Female | Nasopharynx |
Carcinoma | Carcinosarcoma | 45-64 | Male | Nasopharynx |
Sarcoma | Carcinoma | 45-64 | Female | Face/scalp |
Sarcoma | Lymphoma | 15-24 | Male | Maxillofacial bone |
Sarcoma | Lymphoma | 25-44 | Male | Maxillofacial bone |
Lymphoma | Sarcoma | 25-44 | Male | Nose |
Neuroendocrine carcinoma | Sarcoma | 45-64 | Male | Nasopharynx |